200 related articles for article (PubMed ID: 27063183)
1. Update of OECD DART guidelines with endocrine disruptor relevant endpoints: Practical considerations.
Beekhuijzen M; van Otterdijk F; Wieland W; van Tuyl M; Rijcken RP; Peter B; Emmen H
Reprod Toxicol; 2016 Sep; 64():64-71. PubMed ID: 27063183
[TBL] [Abstract][Full Text] [Related]
2. Implementing the extended one-generation reproductive toxicity study (EOGRTS): important points to consider.
Beekhuijzen M; Barentsen H; Marsden E; Zmarowski A; Aujoulat M; Picut C; Sloter E
Crit Rev Toxicol; 2016; 46(4):332-47. PubMed ID: 26941129
[TBL] [Abstract][Full Text] [Related]
3. Developing Test Guidelines on invertebrate development and reproduction for the assessment of chemicals, including potential endocrine active substances- the OECD perspective.
Gourmelon A; Ahtiainen J;
Ecotoxicology; 2007 Feb; 16(1):161-7. PubMed ID: 17219091
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of an OECD reproductive toxicity test guideline with the mudsnail Potamopyrgus antipodarum (Mollusca, Gastropoda).
Ruppert K; Geiß C; Askem C; Benstead R; Brown R; Coke M; Ducrot V; Egeler P; Holbech H; Hutchinson TH; Kinnberg KL; Lagadic L; Le Page G; Macken A; Matthiessen P; Ostermann S; Schimera A; Schmitt C; Seeland-Fremer A; Smith AJ; Weltje L; Oehlmann J
Chemosphere; 2017 Aug; 181():589-599. PubMed ID: 28472747
[TBL] [Abstract][Full Text] [Related]
5. The urgency for optimization and harmonization of thyroid hormone analyses and their interpretation in developmental and reproductive toxicology studies.
Beekhuijzen M; Schneider S; Barraclough N; Hallmark N; Hoberman A; Lordi S; Moxon M; Perks D; Piersma AH; Makris SL
Reprod Toxicol; 2018 Sep; 80():126-130. PubMed ID: 29729334
[TBL] [Abstract][Full Text] [Related]
6. Regulatory acceptance and use of the Extended One Generation Reproductive Toxicity Study within Europe.
Schiffelers MJ; Blaauboer BJ; Bakker WE; Hendriksen CF; Krul C
Regul Toxicol Pharmacol; 2015 Feb; 71(1):114-24. PubMed ID: 25445002
[TBL] [Abstract][Full Text] [Related]
7. The enhancement of the subacute repeat dose toxicity test OECD TG 407 for the detection of endocrine active chemicals: comparison with toxicity tests of longer duration.
Gelbke HP; Hofmann A; Owens JW; Freyberger A
Arch Toxicol; 2007 Apr; 81(4):227-50. PubMed ID: 17047927
[TBL] [Abstract][Full Text] [Related]
8. A critical evaluation of thyroid hormone measurements in OECD test guideline studies: Is there any added value?
Beekhuijzen M; Rijk JCW; Meijer M; de Raaf MA; Pelgrom S
Reprod Toxicol; 2019 Sep; 88():56-66. PubMed ID: 31348994
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of OECD screening tests 421 (reproduction/developmental toxicity screening test) and 422 (combined repeated dose toxicity study with the reproduction/developmental toxicity screening test).
Reuter U; Heinrich-Hirsch B; Hellwig J; Holzum B; Welsch F
Regul Toxicol Pharmacol; 2003 Aug; 38(1):17-26. PubMed ID: 12878050
[TBL] [Abstract][Full Text] [Related]
10. Summary of the development the US Environmental Protection Agency's Medaka Extended One Generation Reproduction Test (MEOGRT) using data from 9 multigenerational medaka tests.
Flynn K; Lothenbach D; Whiteman F; Hammermeister D; Touart LW; Swintek J; Tatarazako N; Onishi Y; Iguchi T; Johnson R
Environ Toxicol Chem; 2017 Dec; 36(12):3387-3403. PubMed ID: 28857258
[TBL] [Abstract][Full Text] [Related]
11. Inter-laboratory control data for reproductive endpoints required in the OPPTS 870.3800/OECD 416 reproduction and fertility test.
Marty MS; Allen B; Chapin RE; Cooper R; Daston GP; Flaws JA; Foster PM; Makris SL; Mylchreest E; Sandler D; Tyl RW
Birth Defects Res B Dev Reprod Toxicol; 2009 Dec; 86(6):470-89. PubMed ID: 19918951
[TBL] [Abstract][Full Text] [Related]
12. The use and acceptance of Other Scientifically Relevant Information (OSRI) in the U.S. Environmental Protection Agency (EPA) Endocrine Disruptor Screening Program.
Bishop PL; Willett CE
Birth Defects Res B Dev Reprod Toxicol; 2014 Feb; 101(1):3-22. PubMed ID: 24151143
[TBL] [Abstract][Full Text] [Related]
13. Guidance on the selection of cohorts for the extended one-generation reproduction toxicity study (OECD test guideline 443).
Moore NP; Beekhuijzen M; Boogaard PJ; Foreman JE; North CM; Palermo C; Schneider S; Strauss V; van Ravenzwaay B; Poole A
Regul Toxicol Pharmacol; 2016 Oct; 80():32-40. PubMed ID: 27245879
[TBL] [Abstract][Full Text] [Related]
14. The underestimated value of OECD 421 and 422 repro screening studies: putting it in the right perspective.
Beekhuijzen M; de Raaf MA; Zmarowski A; van Otterdijk F; Peter B; Emmen H
Reprod Toxicol; 2014 Sep; 48():81-7. PubMed ID: 24768663
[TBL] [Abstract][Full Text] [Related]
15. Multi-criteria decision analysis of test endpoints for detecting the effects of endocrine active substances in fish full life cycle tests.
Crane M; Gross M; Matthiessen P; Ankley GT; Axford S; Bjerregaard P; Brown R; Chapman P; Dorgeloh M; Galay-Burgos M; Green J; Hazlerigg C; Janssen J; Lorenzen K; Parrott J; Rufli H; Schäfers C; Seki M; Stolzenberg HC; van der Hoeven N; Vethaak D; Winfield IJ; Zok S; Wheeler J
Integr Environ Assess Manag; 2010 Jul; 6(3):378-89. PubMed ID: 20821701
[TBL] [Abstract][Full Text] [Related]
16. ESTP comments on the draft updated OECD test guideline 407.
Hartmann E; Strauss V; Eiben R; Freyberger A; Kaufmann W; Loof I; Reissmueller E; Rinke M; Ruehl-Fehlert C; Schorsch F; Schladt L
Exp Toxicol Pathol; 2008 Mar; 59(5):297-300. PubMed ID: 18054214
[TBL] [Abstract][Full Text] [Related]
17. Introduction to "screening for endocrine activity-experiences with the US EPA's endocrine disruptor screening program and future considerations".
Marty S
Birth Defects Res B Dev Reprod Toxicol; 2014 Feb; 101(1):1-2. PubMed ID: 24510782
[No Abstract] [Full Text] [Related]
18. Validation of the OECD reproduction test guideline with the New Zealand mudsnail Potamopyrgus antipodarum using trenbolone and prochloraz.
Geiß C; Ruppert K; Askem C; Barroso C; Faber D; Ducrot V; Holbech H; Hutchinson TH; Kajankari P; Kinnberg KL; Lagadic L; Matthiessen P; Morris S; Neiman M; Penttinen OP; Sanchez-Marin P; Teigeler M; Weltje L; Oehlmann J
Ecotoxicology; 2017 Apr; 26(3):370-382. PubMed ID: 28168557
[TBL] [Abstract][Full Text] [Related]
19. Relevance weighting of tier 1 endocrine screening endpoints by rank order.
Borgert CJ; Stuchal LD; Mihaich EM; Becker RA; Bentley KS; Brausch JM; Coady K; Geter DR; Gordon E; Guiney PD; Hess F; Holmes CM; LeBaron MJ; Levine S; Marty S; Mukhi S; Neal BH; Ortego LS; Saltmiras DA; Snajdr S; Staveley J; Tobia A
Birth Defects Res B Dev Reprod Toxicol; 2014 Feb; 101(1):90-113. PubMed ID: 24510745
[TBL] [Abstract][Full Text] [Related]
20. SIDS reprotoxicity screening test update: testing strategies and use.
Gelbke HP; Fleig H; Meder M;
Regul Toxicol Pharmacol; 2004 Apr; 39(2):81-6. PubMed ID: 15041141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
